首页 > 产品目录 > 免疫学 > 抗体 > Anti-Progesterone Receptor antibody [SP2]

Anti-Progesterone Receptor antibody [SP2]

产品编号 :
英文名称 :
中文名称 :
产品等级 :
品牌 :
包装规格 交货周期 质量标准 目录价 会员专享价 数量
20uL
- +
100uL
- +
500uL
- +
1mL
- +
产品详情
  • 产品名称

    Anti-Progesterone Receptor抗体[SP2]
    参阅全部 Progesterone Receptor 一抗

  • 描述

    兔单克隆抗体[SP2] to Progesterone Receptor

  • 宿主

    Rabbit

  • 经测试应用

    适用于: ICC/IFIHC-PmIHCFlow Cytmore details

  • 种属反应性

    与反应: Human
    预测可用于: Rat, Rabbit

  • 免疫原

    Recombinant fragment. This information is considered to be commercially sensitive.

  • 阳性对照

    • Breast carcinomas IHC-P: Human breast carcinoma tissue. ICC/IF: T-47D cells Flow Cyt: T-47D cells mIHC: Human mammary gland tissue sections, Human triple-positive breast carcinoma tissue sections

  • 常规说明

    This product was switched from a hybridoma to recombinant production method on 13th November 2019.

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.


    This product is FOR RESEARCH USE ONLY. For commercial use, please contact partnerships@abcam.com.

    • - High batch-to-batch consistency and reproducibility

    • - Improved sensitivity and specificity

    • - Long-term security of supply

    • - Animal-free production

  • 形式

    Liquid

  • 存放说明

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. Store In the Dark.

  • 存储溶液

    pH: 7.20
    Preservative: 0.1% Sodium azide
    Constituents: 1% BSA, PBS

  • 浓度

    • 批次浓度范围 100 µl 浓度为 0.075 - 0.08 mg/ml

    • 批次浓度范围 1 ml 浓度为 0.075 - 0.085 mg/ml

    • 500 µl 浓度为 0.075 mg/ml

  • 纯度

    Protein A purified

  • 克隆

    单克隆

  • 克隆编号

    SP2

  • 同种型

    IgG

The Abpromise guarantee

Abpromise™承诺保证使用ab16661于以下的经测试应用

“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。

应用Ab评论说明
ICC/IF

1/100.

IHC-P(3)

1/400. 

Staining of formalin-fixed tissues is required by boiling tissue sections in 10mM citrate buffer, pH 6.0 for 10 min followed by cooling at RT for 20 min.

mIHC

1/6000.

Flow Cyt

1/100. 

ab172730 - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.

  • 数据库链接

    hide

  • 别名

    • PR antibody

    • PRA antibody

    • PRB antibody

    • PRGR_HUMAN antibody

    • Progesterone receptor antibody

    • Progestin receptor form A antibody

    • Progestin receptor form B antibody

    • NR3C3 antibody

    • Nuclear receptor subfamily 3 group C member 3 antibody

    • PGR antibody

  • Multiplex immunohistochemistry - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Multiplex immunohistochemistry - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Multiplex immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human triple-positive breast carcinoma tissue sections labeling Progesterone Receptor (PR) with ab16661, at a 1/6000 dilution ( 0.2 μg/ml). Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins and Opal Polymer HRP Ms + Rb was used as the secondary antibody. DAPI was used as the nuclear counterstain.

    Panel A: merged staining of anti-Progesterone Receptor (PR) (magenta; Opal™690), anti-HER2 (red; Opal™570) and anti-Estrogen Receptor (ER) (green; Opal™520) on human triple-positive breast carcinoma.
    Panel B: anti-PR stained on nucleus of cancer cells.
    Panel C: anti-HER2 stained on membrane of cancer cells.
    Panel D: anti-ER stained on nucleus of cancer cells.

    The section was incubated in three rounds of staining: in the order of ab16661 for 30 mins, then ab16660 and ab231438 for 10 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

    The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  • Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Immunocytochemistry/ Immunofluorescence analysis of T-47D (human ductal breast epithelial tumor epithelial cell) cells labeling Progesterone Receptor with purified ab16661 at 1/100 (2.28 µg/ml). Cells were fixed in 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 µg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1:1000 (2 µg/ml) dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

    This image was generated from the hybridoma version.

     

  • Flow Cytometry - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Flow Cytometry - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Flow Cytometry analysis of T-47D (human ductal breast epithelial tumor epithelial cell) cells labeling Progesterone Receptor with purified ab16661 at 1/220 dilution (1.04 µg/ml) - Red. Cells were fixed with 4% paraformaldehyde . A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1:2000 dilution. Isotype control - Rabbit monoclonal IgG (ab172730) - Black. Unlabeled control - Blue.

    This image was generated from the hybridoma version.

     

  • Multiplex immunohistochemistry - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Multiplex immunohistochemistry - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Multiplex immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human mammary gland tissue sections labeling Progesterone Receptor (PR) with ab16661, at a 1/6000 dilution ( 0.2 μg/ml). Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins and Opal Polymer HRP Ms + Rb was used as the secondary antibody. DAPI was used as the nuclear counterstain.

    Panel A: merged staining of anti-Progesterone Receptor (PR) (magenta; Opal™690), anti-HER2 (red; Opal™570) and anti-Estrogen Receptor (ER) (green; Opal™520) on human mammary gland.
    Panel B: anti-PR stained on nucleus of some ductal cells.
    Panel C: anti-HER2 stained on no cells.
    Panel D: anti-ER stained on nucleus of some ductal cells.

    The section was incubated in three rounds of staining: in the order of ab16661 for 30 mins, then ab16660 and ab231438 for 10 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

    The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  • Multiplex immunohistochemistry - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Multiplex immunohistochemistry - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Multiplex immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human triple-negative breast carcinoma tissue sections labeling Progesterone Receptor (PR) with ab16661, at a 1/6000 dilution ( 0.2 μg/ml). Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins and Opal Polymer HRP Ms + Rb was used as the secondary antibody. DAPI was used as the nuclear counterstain.

    Panel A: merged staining of anti-Progesterone Receptor (PR) (magenta; Opal™690), anti-HER2 (red; Opal™570) and anti-Estrogen Receptor (ER) (green; Opal™520) on human triple-negative breast carcinoma.
    Panel B: anti-PR stained on no cells.
    Panel C: anti-HER2 stained on no cells.
    Panel D: anti-ER stained on no cells.

    The section was incubated in three rounds of staining: in the order of ab16661 for 30 mins, then ab16660 and ab231438 for 10 mins at room temperature. Each round was followed by a separate fluorescent tyramide signal amplification system.

    The immunostaining was performed on a Leica Biosystems BOND® RX instrument with an Opal™ 4-color kit. Image acquisition was performed with Leica SP8 confocal microscope.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Immunohistochemistry analysis of human breast carcinoma tissue labelling SP2 with ab16661.

    This image was generated from the hybridoma version.

     

  • Flow Cytometry - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Flow Cytometry - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Overlay histogram showing T47D cells stained with ab16661 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab16661, 1/100 dilution) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed.

    This image was generated from the hybridoma version.

     

  • Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Immunocytochemistry/ Immunofluorescence - Anti-Progesterone Receptor antibody [SP2] (ab16661)Ding L, et al. (2019), PLOS Genetics, 15(3), e1008002. Fig 3D, DOI: 10.1371/journal.pgen.1008002. Reproduced under the Creative Commons licence. https://creativecommons.org/licenses/by/4.0/

    Rat mammary epithelial cells stained for Pr (pink) using ab16661 at 1/100 dilution in ICC/IF. 

  • Anti-Progesterone Receptor antibody [SP2] (ab16661)

    Anti-Progesterone Receptor antibody [SP2]


浏览记录

抱歉,暂无浏览记录